New & Improved!

Biosimilars
May 2018 : Generic Drugs - Vol. 15 No. 5 - Page #1

Developments in the generic marketplace have an outsized impact on the hospital pharmacy budget. Just as shortages and outsourcer availability issues can lead to unexpected budget spikes, products moving off patent can introduce new opportunities for savings. The promise of savings from the burgeoning biosimilar marketplace remains tantalizing, although drastic price drops have yet to materialize. Most pharmacy departments have introduced biosimilars onto formulary and more are expected to follow. Pharmacy directors have become increasingly comfortable with biosimilar products; this year, for the first time, price outstripped clinical data as the main consideration for including biosimilar products on formulary.

 

Like what you've read? Please log in or create a free account to enjoy more of what www.pppmag.com has to offer.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

    Just answer the following quick question for your chance to win:

    To continue, you must either login or register:

    As of May 24, 2018, www.pppmag.com's Terms of Use and Privacy Policy have been updated.
    You can review the Terms of Use HERE and the Privacy Policy HERE.
    By continuing to use www.pppmag.com, you are agreeing to these changes.